| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -3.8e-05 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 1.9e-05 | 1 |